Evolva sponsors study on resveratrol supplementation in post-menopausal women

By Adi Menayang

- Last updated on GMT

Related tags Research Nutrition

Photo: iStock
Photo: iStock
The study is an extension of an earlier one by the same researchers presented at the 2015 World Diabetes Congress, showing how resveratrol can play a role in slowing cognitive decline in Type 2 diabetes.

Swiss Ingredient company Evolva​ announced that it will sponsor a study to be conducted by the University of Newscastle, Australia, on the effect of daily resveratrol supplementation on cognitive and bone health in postmenopausal women.

Leading the study is Rachel Wong and Peter Howe of the Clinical Nutrition Research Center. The study will add on to an earlier research project​ by Wong, which found that resveratrol can play a role in slowing cognitive decline in Type 2 diabetes. This study was presented at the 2015 World Diabetes Congress.

No date or timeline have been announced yet for this latest study.

“According to the World Health Organisation, the number of individuals over 60 years old with diabetes will increase from 605 million patients to 2 billion,”​ the company said in a press release, highlighting why they feel the study is important. “As people live longer there will be a dramatic increase in the number of older people experiencing diseases linked with ageing and cognitive decline such as dementia and Alzheimer’s.”

Evolva markets resveratrol as a nutritional supplement ingredient in the US and Europe and is currently developing additional human and animal health applications.

Related topics Research Women's health Healthy aging

Related news

Related products

show more

Deliver elevated gummy supplements with ADM

Deliver elevated gummy supplements with ADM

Content provided by ADM: Innovation that Feeds the Future | 15-Jul-2024 | White Paper

We strive to differentiate you from competitors by blending precise ingredient formulas with innovative supplement solutions.

New Dietary Supplement Formulations: Why Use A CDMO

New Dietary Supplement Formulations: Why Use A CDMO

Content provided by Gemini Pharmaceuticals, Inc | 20-Jun-2024 | White Paper

Every Brand Owner wants to bring to market the “latest and greatest” dietary supplement under their label. Often, this “groundbreaking” idea or product...

Next-Gen Women's Health and 'vagina-on-a-chip'

Next-Gen Women's Health and 'vagina-on-a-chip'

Content provided by SGS Nutrasource | 31-May-2024 | Research Study

In the world of health and wellness, particularly in women’s health, there’s a growing trend in prebiotic and probiotic research. For years, women haven’t...

Related suppliers

Follow us

Products

View more

Webinars